Biogen Pharmachem Industries standalone net profit rises 59.46% in the March 2025 quarter

Reported sales nil

Net profit of Biogen Pharmachem Industries rose 59.46% to Rs 1.18 crore in the quarter ended March 2025 as against Rs 0.74 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.29 crore in the year ended March 2025 as against net profit of Rs 1.93 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.

Powered by Capital Market - Live News